I Le Mercier, JL Lines, RJ Noelle - Frontiers in immunology, 2015 - frontiersin.org
In the last two years, clinical trials with blocking antibodies to the negative checkpoint
regulators CTLA-4 and PD-1 have rekindled the hope for cancer immunotherapy. Multiple …